
UniPR505
CAS No. 2938227-14-4
UniPR505( —— )
Catalog No. M36518 CAS No. 2938227-14-4
UniPR505 is a potent EphA2 antagonist (IC50: 0.95 μM), a novel 3α-carbamoyloxy derivative with antiangiogenic properties.
Purity : >98% (HPLC)






Size | Price / USD | Stock | Quantity |
2MG | 787 | Get Quote |
![]() ![]() |
5MG | 1112 | Get Quote |
![]() ![]() |
25MG | 1766 | Get Quote |
![]() ![]() |
50MG | 2190 | Get Quote |
![]() ![]() |
100MG | 2790 | Get Quote |
![]() ![]() |
500MG | Get Quote | Get Quote |
![]() ![]() |
1G | Get Quote | Get Quote |
![]() ![]() |
Biological Information
-
Product NameUniPR505
-
NoteResearch use only, not for human use.
-
Brief DescriptionUniPR505 is a potent EphA2 antagonist (IC50: 0.95 μM), a novel 3α-carbamoyloxy derivative with antiangiogenic properties.
-
DescriptionUniPR505 (Compound 14) is an EphA2 antagonist with an IC50 of 0.95 μM. UniPR505 displays anti-angiogenic properties.
-
In Vitro——
-
In Vivo——
-
Synonyms——
-
PathwayTyrosine Kinase
-
TargetEphrin Receptor
-
RecptorEphrin Receptor
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number2938227-14-4
-
Formula Weight647.89
-
Molecular FormulaC39H57N3O5
-
Purity>98% (HPLC)
-
Solubility——
-
SMILESC[C@@]12[C@]([C@]3([C@@]([C@]4(C)[C@](CC3)(C[C@H](OC(NCC)=O)CC4)[H])(CC1)[H])[H])(CC[C@@]2([C@@H](CCC(N[C@@H](CC=5C=6C(NC5)=CC=CC6)CC(O)=O)=O)C)[H])[H]
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1. Incerti M, et al. Optimization of EphA2 antagonists based on a lithocholic acid core led to the identification of UniPR505, a new 3α-carbamoyloxy derivative with antiangiogenetic properties. Eur J Med Chem. 2020 Mar 1;189:112083. ?
molnova catalog



related products
-
KYL
EphA4 receptor tyrosine kinase inhibitor (Kd = 0.8 μM); inhibits EphA4-EphrinA5 interactions (IC50 = 6.34 μM). Prevents AβO induced synaptic damage, dendritic spine loss and prevents the blocking of LTP in hippocampal CA3-CA1 transmissions. Exhibits a long half life in cell culture media (8 and 12 hours in PC3 and C2C12 media respectively). Neuroprotective.
-
DY-131
DY131 is a novel selective agonist of ERRβ and ERRγ.
-
UniPR505
UniPR505 is a potent EphA2 antagonist (IC50: 0.95 μM), a novel 3α-carbamoyloxy derivative with antiangiogenic properties.